Recombinant human BCMA protein, C-His-Avi (HEK293)

• Catalog Number: orb1516522
• Category: Proteins
• Description: Recombinant human BCMA protein, C-His-Avi (HEK293)
• Target: Tumor necrosis factor receptor superfamily member 17
• Tag: C-His-Avi
• Form/Appearance: Lyophilized
• Concentration: ＞0.5 mg/ml
• Buffer/Preservatives: Lyophilized from 0.22um filtered solution in PBS (pH7.4) with 5mM DTT. Normally 5% trehalose is added as protectant before Lyophilization.
• Purity: > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
• Protein Sequence: 1-54/184
• MW: Due to glycosylation, the protein migrates to 12 and 15-17 kDa based on Tris-Bis PAGE result.
• Application notes: Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
• Expression System: HEK293 cell
• Endotoxins: < 1.0 EU/μg as determined by LAL
• Biological Activity: Not tested
• Storage: Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles.
• Alternative names: B cell maturation antigen; B Cell Maturation Facto
• Note: For research use only

Immobilized Human BCMA at 0.5 ug/ml (100 ul/Well). Dose response curve for Anti-Human BCMA Ab. with the EC50 of 54.5 ng/ml determined by ELISA.

Immobilized Human BCMA, His Tag at 1 ug/ml (100 ul/Well). Dose response curve for Human BAFF, Fc Tag with the EC50 of 57 ng/ml determined by ELISA.

Recombinant BCMA on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.